Indiana University Research and Technology Corporation
发明人:
Mark R. Kelley,Reuben Kapur
申请号：
US16480010
公开号：
US20190350885A1
申请日:
2018.01.18
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compounds, and methods and uses of compounds, and pharmaceutical compositions thereof, are described herein for treating myeloid malignancies. In particular, compounds, and methods and uses of compounds, and pharmaceutical compositions thereof, are described herein for treating acute myeloid leukemia (AML), myeloproliferative neoplasm (MPN), and/or myelodysplastic syndrome (MDS).
